查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1609027

元基因組體定序市場：依產品/服務、工作流程、技術、應用分類 - 2025-2030 年全球預測

Metagenomic Sequencing Market by Product & Service, Workflow, Technology, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年元基因組體定序市值為21.5億美元，預計2024年將達23.9億美元，複合年成長率為12.43%，到2030年將達到48.9億美元。

元基因組組定序是基因體學的突破性方法，可分析環境樣本的遺傳物質，無需培養即可對微生物群落進行全面研究。這種方法對於了解土壤、海洋和人類腸道微生物組等環境中的複雜微生物組至關重要。其應用涵蓋各個領域，包括檢測病原體爆發的臨床診斷、評估土壤健康的農業以及清理污染物的生物修復活動。最終用途多種多樣，包括製藥業、環境機構、學術研究機構和醫療保健。定序技術的進步、人們對微生物組在健康中作用的認知的提高以及研發投資的增加推動了市場的開拓。新的商機出現在個人化醫療和農業領域，其中元基因組分析根據個人的微生物組組成提供量身定做的健康解決方案，而農業則提供永續的作物管理解決方案。挑戰包括高成本、資料分析的複雜性以及阻礙資料解釋的參考資料資料庫的局限性。透過生物資訊工具的創新、降低定序成本和加強跨產業合作來應對這些挑戰，有可能推動市場擴張。研究創新的關鍵部分包括開發更快、更具成本效益的定序技術和預測分析，以準確解釋複雜的元基因組資料。該市場的特點是技術快速發展，並且隨著公司努力提供差異化解決方案而競爭激烈。對於希望利用這一市場的公司的建議包括投資先進定序平台的研發、技術交流策略聯盟以及全面的微生物組分析和解釋服務，其中包括專注於擴大服務範圍。總體而言，元基因組組定序在各個領域的整合凸顯了其變革潛力，但市場參與企業必須克服挑戰並利用永續成長的機會。

主要市場統計
基準年[2023] 21.5億美元
預測年份 [2024] 23.9億美元
預測年份 [2030] 48.9億美元
複合年成長率（%） 12.43%

市場動態：揭示快速發展的元基因組定序市場的關鍵市場洞察

供需的動態交互作用正在改變元基因組組定序市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 評估細菌多樣性和檢測各種微生物的需求日益增加
    • 遺傳疾病在世界各地的傳播
    • 增加政府和私營部門對定序計劃的投資
  • 市場限制因素
    • 定序資料的儲存空間有限
    • 開發中國家最終用戶的高價格
  • 市場機會
    • 元基因組序列資料管理的技術進步
    • 更好的元基因組組定序的技術開發
  • 市場問題
    • 缺乏技術精湛、經驗豐富的人才

波特五力：駕馭元基因組定序市場的策略工具

波特的五力架構是了解元基因組體定序市場競爭格局的關鍵工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解元基因組體定序市場的外部影響

外部宏觀環境因素在塑造元基因組定序市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解元基因組體定序市場的競爭格局

元基因組組定序市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣：元基因組定序市場供應商績效評估

FPNV定位矩陣是評估元基因組定序市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製元基因組定序市場的成功之路

對於想要加強在全球市場的影響力的公司來說，元基因組定序市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：詳細檢視當前市場環境，主要企業的廣泛資料，評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、主要產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 評估細菌多樣性和檢測各種微生物的需求日益增加
      • 世界各地遺傳性疾病的發生率正在增加
      • 政府和私營部門增加對定序計劃的投資
    • 抑制因素
      • 序列資料儲存容量有限
      • 對於新興國家的最終用戶來說價格較高
    • 機會
      • 元基因組序列資料管理的技術進步
      • 更好的元基因組組定序的技術開發
    • 任務
      • 缺乏熟練且經驗豐富的勞動力
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章元基因組體定序市場：依產品及服務分類

  • 介紹
  • 分析和資料解釋解決方案
  • 裝置
  • 試劑/耗材
  • 服務

第7章元基因組體定序市場：依工作流程

  • 介紹
  • 資料處理與分析
  • 樣品處理和文庫製備
  • 定序

第8章元基因組體定序市場：依技術分類

  • 介紹
  • 16S rRNA定序
  • 元轉錄組學
  • 鳥槍法宏基因組定序
  • 全基因測序與從頭組裝

第9章元基因組體定序市場：依應用分類

  • 介紹
  • 臨床診斷
  • 藥物發現
  • 生態學與環境應用
  • 工業用途
  • 土壤微生物組應用
  • 獸醫應用

第10章美洲元基因組定序市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太宏元基因組定序市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲元基因組定序市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Azenta US, Inc.
  • BGI Genomics Co., Ltd.
  • CosmosID
  • DNASTAR, Inc.
  • Eurofins Genomics Germany GmbH
  • Freenome Holdings, Inc.
  • IntegraGen SA
  • Macrogen Europe BV
  • Microsynth AG
  • Novogene Co., Ltd.
  • Oxford Nanopore Technologies PLC
  • Pacific Biosciences of California, Inc.
  • PerkinElmer Inc.
  • Psomagen, Inc.
  • QIAGEN GmbH
Product Code: MRR-E3708867678B

The Metagenomic Sequencing Market was valued at USD 2.15 billion in 2023, expected to reach USD 2.39 billion in 2024, and is projected to grow at a CAGR of 12.43%, to USD 4.89 billion by 2030.

Metagenomic sequencing is a revolutionary approach in genomics that analyzes the genetic material from environmental samples, enabling the comprehensive study of microbial communities without the need for culturing. This approach is crucial for understanding complex microbiomes in environments such as soil, oceans, and human gut flora. Its applications span multiple fields, including clinical diagnostics, where it aids in detecting pathogen outbreaks, agriculture for soil health assessment, and bioremediation efforts to clean pollutants. The end-use scope extends across pharmaceutical industries, environmental agencies, academic research institutions, and healthcare. Market growth is driven by technological advancements in sequencing technologies, growing awareness about microbiomes' roles in health, and increased investment in research and development. Emerging opportunities lie in personalized medicine, where metagenomics can offer tailored health solutions based on individual microbiome compositions, and in agriculture, providing sustainable crop management solutions. Challenges include high costs, data analysis complexity, and limited reference databases, which can impede data interpretation. Addressing these challenges through innovation in bioinformatics tools, reducing sequencing costs, and enhancing cross-industry collaborations could facilitate market expansion. Key areas for research innovation include developing faster, more cost-effective sequencing technologies and predictive analytics to interpret complex metagenomic data accurately. The market is characterized by rapid technological evolution, leading to a highly competitive landscape as companies strive to offer differentiated solutions. Recommendations for businesses looking to capitalize on this market involve investing in R&D for advanced sequencing platforms, forming strategic alliances for technology exchange, and focusing on expanding service offerings to include comprehensive microbiome profiling and interpretation services. Overall, the integration of metagenomic sequencing in various sectors highlights its transformative potential, but market participants must navigate challenges and leverage opportunities for sustainable growth.

KEY MARKET STATISTICS
Base Year [2023] USD 2.15 billion
Estimated Year [2024] USD 2.39 billion
Forecast Year [2030] USD 4.89 billion
CAGR (%) 12.43%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Metagenomic Sequencing Market

The Metagenomic Sequencing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising need for the evaluation of bacterial diversity and detection of various microbes
    • Growing prevalence of genetic disorders worldwide
    • Rising investment by government and private sector for sequencing projects
  • Market Restraints
    • Limited storage for the sequencing data
    • High price for the end-user in developing countries
  • Market Opportunities
    • Technological advancement for the metagenomic sequencing data management
    • Technological development for better metagenomic sequencing
  • Market Challenges
    • Dearth of skilled and experienced workforce

Porter's Five Forces: A Strategic Tool for Navigating the Metagenomic Sequencing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Metagenomic Sequencing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Metagenomic Sequencing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Metagenomic Sequencing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Metagenomic Sequencing Market

A detailed market share analysis in the Metagenomic Sequencing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Metagenomic Sequencing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Metagenomic Sequencing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Metagenomic Sequencing Market

A strategic analysis of the Metagenomic Sequencing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Metagenomic Sequencing Market, highlighting leading vendors and their innovative profiles. These include Azenta US, Inc., BGI Genomics Co., Ltd., CosmosID, DNASTAR, Inc., Eurofins Genomics Germany GmbH, Freenome Holdings, Inc., IntegraGen S.A., Macrogen Europe BV, Microsynth AG, Novogene Co., Ltd., Oxford Nanopore Technologies PLC, Pacific Biosciences of California, Inc., PerkinElmer Inc., Psomagen, Inc., and QIAGEN GmbH.

Market Segmentation & Coverage

This research report categorizes the Metagenomic Sequencing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product & Service, market is studied across Analysis & Data Interpretation Solutions, Instruments, Reagents & Consumables, and Services.
  • Based on Workflow, market is studied across Data Processing & Analysis, Sample Processing & Library Preparation, and Sequencing.
  • Based on Technology, market is studied across 16S rRNA Sequencing, Metatranscriptomics, Shotgun Metagenomic Sequencing, and Whole-genome Sequencing & De Novo Assembly.
  • Based on Application, market is studied across Clinical Diagnostics, Drug Discovery, Ecological & Environmental Applications, Industrial applications, Soil Microbiome Applications, and Veterinary Applications.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising need for the evaluation of bacterial diversity and detection of various microbes
      • 5.1.1.2. Growing prevalence of genetic disorders worldwide
      • 5.1.1.3. Rising investment by government and private sector for sequencing projects
    • 5.1.2. Restraints
      • 5.1.2.1. Limited storage for the sequencing data
      • 5.1.2.2. High price for the end-user in developing countries
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement for the metagenomic sequencing data management
      • 5.1.3.2. Technological development for better metagenomic sequencing
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of skilled and experienced workforce
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Metagenomic Sequencing Market, by Product & Service

  • 6.1. Introduction
  • 6.2. Analysis & Data Interpretation Solutions
  • 6.3. Instruments
  • 6.4. Reagents & Consumables
  • 6.5. Services

7. Metagenomic Sequencing Market, by Workflow

  • 7.1. Introduction
  • 7.2. Data Processing & Analysis
  • 7.3. Sample Processing & Library Preparation
  • 7.4. Sequencing

8. Metagenomic Sequencing Market, by Technology

  • 8.1. Introduction
  • 8.2. 16S rRNA Sequencing
  • 8.3. Metatranscriptomics
  • 8.4. Shotgun Metagenomic Sequencing
  • 8.5. Whole-genome Sequencing & De Novo Assembly

9. Metagenomic Sequencing Market, by Application

  • 9.1. Introduction
  • 9.2. Clinical Diagnostics
  • 9.3. Drug Discovery
  • 9.4. Ecological & Environmental Applications
  • 9.5. Industrial applications
  • 9.6. Soil Microbiome Applications
  • 9.7. Veterinary Applications

10. Americas Metagenomic Sequencing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Metagenomic Sequencing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Metagenomic Sequencing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Azenta US, Inc.
  • 2. BGI Genomics Co., Ltd.
  • 3. CosmosID
  • 4. DNASTAR, Inc.
  • 5. Eurofins Genomics Germany GmbH
  • 6. Freenome Holdings, Inc.
  • 7. IntegraGen S.A.
  • 8. Macrogen Europe BV
  • 9. Microsynth AG
  • 10. Novogene Co., Ltd.
  • 11. Oxford Nanopore Technologies PLC
  • 12. Pacific Biosciences of California, Inc.
  • 13. PerkinElmer Inc.
  • 14. Psomagen, Inc.
  • 15. QIAGEN GmbH

LIST OF FIGURES

  • FIGURE 1. METAGENOMIC SEQUENCING MARKET RESEARCH PROCESS
  • FIGURE 2. METAGENOMIC SEQUENCING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. METAGENOMIC SEQUENCING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. METAGENOMIC SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. METAGENOMIC SEQUENCING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. METAGENOMIC SEQUENCING MARKET DYNAMICS
  • TABLE 7. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY ANALYSIS & DATA INTERPRETATION SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY DATA PROCESSING & ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY SAMPLE PROCESSING & LIBRARY PREPARATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY 16S RRNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY METATRANSCRIPTOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY WHOLE-GENOME SEQUENCING & DE NOVO ASSEMBLY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY ECOLOGICAL & ENVIRONMENTAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY INDUSTRIAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY SOIL MICROBIOME APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY VETERINARY APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. METAGENOMIC SEQUENCING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 197. METAGENOMIC SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2023